HARTALEGA HOLDINGS Hartalega Holdings Share Price
Equities
HARTA
MYL5168OO009
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.82 MYR | +29.05% |
|
+31.27% | +41.48% |
| Sales 2024 * | 1.97B 421M 33.18B | Sales 2025 * | 2.51B 535M 42.19B | Capitalization | 13.04B 2.78B 220B |
|---|---|---|---|---|---|
| Net income 2024 * | 49M 10.47M 825M | Net income 2025 * | 182M 38.87M 3.06B | EV / Sales 2024 * | 5.78 x |
| Net cash position 2024 * | 1.64B 351M 27.64B | Net cash position 2025 * | 1.66B 354M 27.94B | EV / Sales 2025 * | 4.54 x |
| P/E ratio 2024 * |
214
x | P/E ratio 2025 * |
62.4
x | Employees | 7,562 |
| Yield 2024 * |
0.19% | Yield 2025 * |
0.82% | Free-Float | 43.99% |
More Fundamentals
* Assessed data
More news
| 1 day | +29.05% | ||
| 1 week | +31.27% | ||
| Current month | +36.43% | ||
| 1 month | +43.07% | ||
| 3 months | +46.92% | ||
| 6 months | +62.55% | ||
| Current year | +41.48% |
1 week
2.91
3.83
1 month
2.613.83
Current year
2.403.83
1 year
1.883.83
3 years
1.4110.06
5 years
1.4121.16
10 years
1.4121.16
| Managers | Title | Age | Since |
|---|---|---|---|
Mun Leong Kuan
CEO | Chief Executive Officer | 48 | 06/05/07 |
Kean Wooi Loh
DFI | Director of Finance/CFO | 49 | 09/02/20 |
Wah Choon Leang
CTO | Chief Tech/Sci/R&D Officer | 49 | 12/07/15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 01/03/15 | |
Guan Cheong Tan
BRD | Director/Board Member | 80 | 30/12/11 |
Mun Leong Kuan
CEO | Chief Executive Officer | 48 | 06/05/07 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.67% | 4 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/05/24 | 3.82 | +29.05% | 84,894,700 |
| 14/05/24 | 2.96 | -1.33% | 4,382,800 |
| 13/05/24 | 3 | 0.00% | 7,731,800 |
| 10/05/24 | 3 | +3.81% | 15,845,000 |
| 09/05/24 | 2.89 | -0.69% | 3,290,400 |
End-of-day quote BURSA MALAYSIA, May 14, 2024
More quotes
Hartalega Holdings Berhad is an investment holding company. The Company is engaged in the manufacture and sale of latex gloves. The Company also offers Nitrile gloves, Polyisoprene and Specialty gloves. The Company's Nitrile gloves products include Nitrile Powder Free 2.5 Mil, Nitrile Powder Free 3.2 Mil, Nitrile Powder Free 3.5 Mil, Nitrile Powder Free 3.5 Mil Extended Cuff, Coats Colloidal Oatmeal Coated Nitrile Powder Free 2.5 Mil, Class 100 Cleanroom Semiconductor Nitrile 4.5 Mil, Nitrile Powder Free 8.0 Mil Extended Cuff, Nitrile Powder Free 4.5 Mil Extended Cuff and Nitrile Powder Free 4.8 Mil Extended Cuff. The Company's latex gloves products include Latex Powdered 4.0 Mil, Latex Powdered 3.0 Mil, Latex Powdered 5.0 Mil, Coats Colloidal Oatmeal Coated Latex Powder Free 4.5 Mil, Latex Powder Free 4.0 Mil, Latex Powder Free 4.5 Mil, Latex Powder Free 5.0 Mil, Surgical Latex Powder Free 7.5 Mil, Latex Polymer Coated 5.5 Mil and Surgical Latex Powdered 7.5 Mil.
Calendar
05/08/2024
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
3.82
MYR
Average target price
2.633
MYR
Spread / Average Target
-31.07%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +41.48% | 2.77B | |
| +8.81% | 27.43B | |
| -29.70% | 3.14B | |
| -18.39% | 2.46B | |
| +12.41% | 2.36B | |
| +40.00% | 2.14B | |
| -1.23% | 2.09B | |
| +48.11% | 1.49B | |
| +3.80% | 1.37B | |
| +9.73% | 1.19B |
- Stock Market
- Equities
- HARTA Stock
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return**#ffffff**/services/solutions/**#004eff**#000000**Replicate our performance**1**
